One-year Observation of Safety of Implantable Collamer Lens V4c Implantation Without Using an Ophthalmic Viscosurgical Device
Zhuoyi Chen,Lingling Niu,Jing Zhao,Peijun Yao,Xiaoying Wang,Xingtao Zhou
DOI: https://doi.org/10.3389/fmed.2022.790137
IF: 3.9
2022-01-01
Frontiers in Medicine
Abstract:PurposeTo investigate the feasibility and safety of the implantable collamer lens V4c (ICL V4c) implantation without using an ophthalmic viscosurgical device (OVD-free technique). MethodsThis prospective consecutive case study enrolled 118 eyes of 60 patients (15 eyes were of male patients, 103 eyes were of female patients, age 26.19 +/- 5.03 years, spherical equivalent -10.05 +/- 2.73 D). Eyes were considered for OVD-free or OVD-using ICL V4c implantation based on the maintenance of the anterior segment during the surgery. The follow-up lasted for 12 months. The main measurements were visual acuity and changes in endothelial cell density (ECD) at 12 months. ResultsA total of 75 eyes were included in the OVD-free group and 43 in the OVD group. No infection or other complications were observed in any eye. In the OVD-free group, the safety and efficacy indices were 1.19 +/- 0.15 and 1.05 +/- 0.20, respectively. 74.5% of the eyes gained one or two lines of corrected distance visual acuity (CDVA), and 25.5% were stable. In the OVD group, the safety and efficacy indices were 1.17 +/- 0.17 and 1.03 +/- 0.15, respectively; 65.7% of the eyes gained one or two lines of CDVA, and 34.3% were stable. The mean change of ECD was 65.34 cell/ mm(2) compared to the baseline in the OVD-free group and 25.94 cell/ mm(2) compared to baseline in the OVD group (P = 0.038). ConclusionsThe ICL V4c implantation with an OVD-free technique is a safe and feasible method in eyes with good maintenance of the anterior segment.
What problem does this paper attempt to address?